Amphastar Pharmaceuticals (NASDAQ:AMPH) held its virtual annual meeting of stockholders on June 1, with shareholders approving all matters presented, according to the meeting transcript.
Bill Peters, Amphastar’s Chief Financial Officer, Board Member, Executive Vice President of Finance and Treasurer, opened the meeting and introduced directors, executive officers and representatives from the company’s outside counsel, independent public accounting firm and election services provider. Dr. Mary Luo, Chairperson of the Board, Chief Operating Officer and Chief Scientist, was designated to act as chairperson of the meeting, while Jacob Liawatidewi, Corporate Secretary, was designated to record the minutes.
Shareholders Elect Three Class I Directors
Stockholders elected David Gaugh, William J. Peters and Jacob Liawatidewi to serve as Class I directors until the company’s 2029 annual meeting of stockholders. Dischner said all three nominees were already serving as members of Amphastar’s board of directors.
Amphastar’s board has 10 members divided into three classes, with directors serving three-year terms. Dischner said the board is composed of three Class I directors, four Class II directors and three Class III directors.
Auditor Ratification and Compensation Votes Approved
Shareholders also ratified the appointment of Ernst & Young LLP as Amphastar’s independent registered public accounting firm for the fiscal year ending Dec. 31, 2026. Dischner noted that if stockholders did not ratify the selection, the board could reconsider the appointment.
In addition, shareholders approved, on an advisory basis, the compensation of Amphastar’s named executive officers. Dischner said the vote is non-binding, but the board will consider the outcome when making future compensation decisions for executive officers.
Stockholders also approved an annual frequency for future advisory votes on named executive officer compensation. The board had recommended that these say-on-pay votes occur every one year.
Preliminary Results Announced
Dischner said the inspector of election had confirmed a quorum before the meeting proceeded. The online polls opened at 11:36 a.m. and closed at 11:39 a.m. local meeting time.
The preliminary voting results announced at the meeting were:
- David Gaugh, William J. Peters and Jacob Liawatidewi were elected as Class I directors.
- The appointment of Ernst & Young LLP as independent auditor was ratified.
- The advisory vote on named executive officer compensation was approved.
- Stockholders indicated a preference for annual future advisory votes on executive compensation.
Dischner said the final vote count may vary after a final review of proxies and ballots. He said final results will be included in the inspector of election’s report, recorded in the meeting minutes and reported in a Form 8-K to be filed with the Securities and Exchange Commission within four days of the meeting.
No Stockholder Questions Submitted
After the formal meeting was adjourned, Amphastar opened a question-and-answer period for stockholders. Dischner said representatives of the company could make forward-looking statements during the session and referred investors to Amphastar’s recent SEC filings, including its Form 10-K filed Feb. 26, 2026, and Form 10-Q filed May 7, 2026, for risk factors.
No stockholder questions were submitted through the web portal. The company thanked attendees for their interest and support before concluding the call.
About Amphastar Pharmaceuticals (NASDAQ:AMPH)
Amphastar Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Rancho Cucamonga, California. Founded in 2004, Amphastar focuses on the development, manufacturing and commercialization of injectable and inhalation products. The company’s manufacturing facilities in California produce both generic and proprietary formulations designed to address urgent and chronic medical conditions.
Amphastar’s portfolio includes a range of injectable generics such as epinephrine, naloxone and lidocaine, serving hospital, emergency medical and retail pharmacy channels.
